The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-Chloro-5-(4-chlorophenyl)-3-phenyl-thiazolo[4,5-d]pyrimidin-2-one ID: ALA2298127
PubChem CID: 76334991
Max Phase: Preclinical
Molecular Formula: C17H9Cl2N3OS
Molecular Weight: 374.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=c1sc2c(Cl)nc(-c3ccc(Cl)cc3)nc2n1-c1ccccc1
Standard InChI: InChI=1S/C17H9Cl2N3OS/c18-11-8-6-10(7-9-11)15-20-14(19)13-16(21-15)22(17(23)24-13)12-4-2-1-3-5-12/h1-9H
Standard InChI Key: LLQZEQYBGBMNJS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
17.8612 -3.1078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8601 -3.9273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5681 -4.3363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5663 -2.6989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5679 -5.1535 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.2750 -3.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2752 -3.9228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0539 -4.1755 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.5349 -3.5131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0527 -2.8517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3521 -3.5128 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4610 -2.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2793 -2.1492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6894 -1.4432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2823 -0.7336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4609 -0.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0545 -1.4410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1555 -2.6995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1566 -1.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4497 -1.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7411 -1.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7439 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4514 -3.1078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0327 -1.4742 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
3 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 6 1 0
9 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
1 18 1 0
21 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.25Molecular Weight (Monoisotopic): 372.9843AlogP: 4.82#Rotatable Bonds: 2Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 6.07CX LogD: 6.07Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.47Np Likeness Score: -1.56
References 1. Becan L, Wagner E.. (2013) Synthesis and anticancer evaluation of novel 3,5-diaryl-thiazolo[4,5-d]pyrimidin-2-one derivatives., 22 (5): [PMID:23543906 ] [10.1007/s00044-012-0231-7 ]